Credit Agricole
ZVRA icon

Credit Agricole’s Zevra Therapeutics ZVRA Stock Holding History

Credit Agricole’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Hold
106,000
– – ﹤0.01% 1038
2026
Q1 		$988K Hold
106,000
– – ﹤0.01% 1077
2025
Q4 		$950K Buy
+106,000
New +$1M ﹤0.01% 1056
2025
Q1 		$794K Hold
106,000
– – ﹤0.01% 963
2024
Q4 		$884K Hold
106,000
– – ﹤0.01% 962
2024
Q3 		$736K Hold
106,000
– – ﹤0.01% 869
2024
Q2 		$519K Buy
+106,000
New +$502K ﹤0.01% 824

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Agricole's ZVRA Position: Q2 2026 in Review

Credit Agricole held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 106,000 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Credit Agricole first reported a position in ZVRA in Q2 2024 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Credit Agricole held 106,000 shares of Zevra Therapeutics worth $1.52M as of Q2 2026.
  • Credit Agricole left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1038 holding.
  • Credit Agricole first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.